Details for New Drug Application (NDA): 074430

NDA 074430 describes DESIPRAMINE HYDROCHLORIDE, which is a drug marketed by Actavis Totowa, Alembic, Amneal Pharms Co, Ani Pharms, Chartwell Rx, Heritage, Novast Labs, and Usl Pharma, and is included in sixteen NDAs. It is available from nine suppliers. Additional details are available on the DESIPRAMINE HYDROCHLORIDE profile page.

The generic ingredient in DESIPRAMINE HYDROCHLORIDE is desipramine hydrochloride. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.

Summary for 074430

Tradename:	DESIPRAMINE HYDROCHLORIDE
Applicant:	Actavis Totowa
Ingredient:	desipramine hydrochloride
Patents:	0

Pharmacology for NDA: 074430

Medical Subject Heading (MeSH) Categories for 074430

Adrenergic Uptake Inhibitors

Antidepressive Agents, Tricyclic

Enzyme Inhibitors

Suppliers and Packaging for NDA: 074430

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	074430	ANDA	Actavis Pharma, Inc.	45963-341	45963-341-02	100 TABLET, FILM COATED in 1 BOTTLE (45963-341-02)
DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	074430	ANDA	Actavis Pharma, Inc.	45963-346	45963-346-50	50 TABLET, FILM COATED in 1 BOTTLE (45963-346-50)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	10MG
Approval Date:	Feb 9, 1996	TE:	AB	RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	150MG
Approval Date:	Feb 9, 1996	TE:	AB	RLD:	No

Complete Access Available with Subscription